High-throughput CETSA to Measure Intracellular Compound Target Engagement in Early Drug Discovery (IMAGE)
Caption
An evaluation of high-throughput CETSA for hit identification and SAR screening with comparisons to alternative assay formats demonstrates the technology can be robustly and reliably applied throughout early drug discovery.
Credit
Joseph Shaw, AstraZeneca
Usage Restrictions
None
License
Licensed content